Lactoferrin: all 47 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Lactoferrin Supplementation in Diabetic NephropathyRecruitingNCT07764991Phase 2
• A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising FemalesRecruitingNCT07546591Not applicable
• The Effect of Lactoferrin on Pain Management Following Cesarean SectionNot yet recruitingNCT07502235Phase 3
• Efficacy and Safety of Lactoferrin in Heart Failure PatientsNot yet recruitingNCT06427200Phase 4
• Metformin and Lactoferrin in Sepsis in IcuRecruitingNCT06181422Phase 2/3
• Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of AnemiaNot yet recruitingNCT05921968Phase 4
• Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea SequelaeRecruitingNCT05519254Phase 3
• Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth RestrictionRecruitingNCT05038462Not applicable
• Management of Iron Deficiency Anemia in Hemodialysis PatientsActive, not recruitingNCT07706582Phase 2
• Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency AnemiaCompletedNCT06590831Not applicable
• Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis RatsCompletedNCT06491394Phase 4
• Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During PregnancyCompletedNCT06252103Phase 4
• Lactoferrin Use in ICU PatientsCompletedNCT05936528Phase 4
• Lactoferrin for COVID-19-Induced Taste or Smell AbnormalityWithdrawnNCT05760079Not applicable
• Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD ChildrenStatus unknownNCT05714176Phase 4
• Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in PregnancyStatus unknownNCT05669963Phase 2/3
• Effect of Lactoferrin in Pneumonia TreatmentStatus unknownNCT05431023Not applicable
• Lactoferrin Use in (SARS-CoV-2) ManagementStatus unknownNCT04860219Not applicable
• An Outpatient Study Investigating Non-prescription Treatments for COVID-19TerminatedNCT04621149Phase 2
• Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic PatientsCompletedNCT04475120Phase 2/3
• Lactoferrin for Treatment of Iron Deficiency Anemia.CompletedNCT04435574Phase 4
• Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19Status unknownNCT04421534Phase 2/3
• Lactoferrin in Treatment of Fe Deficient Anemia In CirrhosisStatus unknownNCT04335058Not applicable
• Safety and Efficacy of Oral Bovine LactoferrinCompletedNCT04094597Early Phase 1
• Antibiotic Therapy in Erupted Tooth ExtractionsCompletedNCT04082598Phase 4
• Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams StudentsCompletedNCT03940430Phase 2/3
• Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During PregnancyCompletedNCT03759353Phase 2
• the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic TonsillitisStatus unknownNCT03748043Phase 4
• The Effectiveness of Lactoferrin in the Management of Treatment-induced AnemiaStatus unknownNCT03683810Phase 1
• Oral Lactoferrin Versus Iron Supplementation During PregnancyCompletedNCT03542825Phase 4
• Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During PregnancyStatus unknownNCT03484845Phase 1/2
• Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During PregnancyCompletedNCT03481790Phase 2
• Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of NursingCompletedNCT03279536Phase 1/2
• Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During PregnancyStatus unknownNCT03202615Phase 4
• Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight InfantsStatus unknownNCT03163212Early Phase 1
• Early Versus Late Lactoferrin in Prevention of Neonatal SepsisCompletedNCT02959229Phase 4
• Lactoferrin and Lysozyme Supplementation for Environmental Enteric DysfunctionCompletedNCT02925026Not applicable
• Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy ComplicationsCompletedNCT02843984Not applicable
• Safety and Tolerability of Lactoferrin in Very Low Birth Weight InfantsStatus unknownNCT02731092Phase 1
• Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory MediatorsCompletedNCT02695563Phase 2
• Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL StudyCompletedNCT01996579Phase 2
• Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm NeonateStatus unknownNCT01821989Early Phase 1
• Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult PatientsStatus unknownNCT01382199Phase 3
• Lactoferrin Prophylaxis in VLBW and Regulator T-cellsCompletedNCT01287507Not applicable
• Pilot Study: Lactoferrin for Prevention of Neonatal SepsisCompletedNCT01264536Phase 2
• Supplementation With Lactoferrin in Preterm NewbornsCompletedNCT01172236Phase 4
• Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common ColdCompletedNCT01092039Not applicable

← Lactoferrin overview